Total Payments
$25,013
2024 Payments
$2,280
Companies
52
Transactions
905
Medicare Patients
9,834
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$16,160 (64.6%)
Other$4,500 (18.0%)
Travel$4,277 (17.1%)
Education$76.84 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,160 | 878 | 64.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,500 | 2 | 18.0% |
| Travel and Lodging | $4,277 | 20 | 17.1% |
| Education | $76.84 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $9,911 | 207 | $0 (2024) |
| ABIOMED | $1,439 | 11 | $0 (2024) |
| Edwards Lifesciences Corporation | $1,363 | 13 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $1,262 | 78 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,219 | 73 | $0 (2024) |
| PFIZER INC. | $1,147 | 87 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,048 | 81 | $0 (2024) |
| Abbott Laboratories | $926.91 | 31 | $0 (2024) |
| The Spectranetics Corporation | $893.87 | 11 | $0 (2017) |
| Amgen Inc. | $686.68 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,280 | 104 | Boston Scientific Corporation ($574.14) |
| 2023 | $2,714 | 151 | Boston Scientific Corporation ($790.61) |
| 2022 | $2,404 | 137 | Boston Scientific Corporation ($790.66) |
| 2021 | $1,981 | 118 | BOSTON SCIENTIFIC CORPORATION ($827.64) |
| 2020 | $2,712 | 64 | Boston Scientific Corporation ($1,820) |
| 2019 | $5,163 | 114 | Boston Scientific Corporation ($3,946) |
| 2018 | $4,640 | 126 | Edwards Lifesciences Corporation ($1,363) |
| 2017 | $3,120 | 91 | BOSTON SCIENTIFIC CORPORATION ($981.26) |
All Payment Transactions
905 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/17/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $18.80 | General |
| 12/16/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $8.35 | General |
| Category: Cardiovascular | ||||||
| 12/05/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $40.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/03/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $99.00 | General |
| Category: Coronary | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $27.92 | General |
| Category: Cardiovascular | ||||||
| 11/14/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $39.56 | General |
| Category: Medical Device | ||||||
| 11/12/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $6.00 | General |
| Category: Cardiovascular | ||||||
| 11/05/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/01/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.22 | General |
| Category: Cardiovascular | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Cardio-pulmonary | ||||||
| 10/21/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $19.92 | General |
| 10/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.31 | General |
| 10/15/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $23.84 | General |
| Category: Medical Device | ||||||
| 10/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/03/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Cardiology | ||||||
| 10/03/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Cardiology | ||||||
| 10/01/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/25/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: General - Structural Heart_IC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,656 | 4,573 | $900,658 | $282,035 |
| 2022 | 29 | 2,546 | 4,419 | $838,773 | $264,494 |
| 2021 | 28 | 2,348 | 4,009 | $806,388 | $268,824 |
| 2020 | 28 | 2,284 | 4,108 | $767,410 | $225,753 |
Total Patients
9,834
Total Services
17,109
Medicare Billing
$1.0M
Procedure Codes
116
All Medicare Procedures & Services
116 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 719 | 1,113 | $301,623 | $132,942 | 44.1% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 58 | 66 | $116,754 | $27,078 | 23.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 122 | 294 | $40,572 | $17,185 | 42.4% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 114 | 118 | $92,630 | $16,893 | 18.2% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 56 | 278 | $33,360 | $11,253 | 33.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 65 | 65 | $25,220 | $9,269 | 36.8% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 98 | 144 | $26,208 | $8,178 | 31.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 125 | 392 | $40,376 | $7,900 | 19.6% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 21 | 21 | $34,671 | $6,357 | 18.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 63 | 63 | $16,506 | $6,066 | 36.7% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 125 | 392 | $36,848 | $5,787 | 15.7% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 55 | 273 | $22,659 | $4,777 | 21.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 36 | $13,860 | $4,722 | 34.1% |
| 93455 | Insertion of tube in bypass graft for diagnosis with review by radiologist | Facility | 2023 | 24 | 27 | $24,462 | $4,569 | 18.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 23 | 39 | $8,268 | $4,218 | 51.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 439 | 512 | $13,824 | $3,063 | 22.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $11,484 | $2,088 | 18.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 162 | 175 | $6,650 | $1,661 | 25.0% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 71 | 74 | $4,958 | $1,271 | 25.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 20 | 20 | $2,740 | $1,186 | 43.3% |
| 33285 | Insertion of heart rhythm monitor under skin | Facility | 2023 | 19 | 19 | $5,339 | $1,158 | 21.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 91 | 96 | $5,568 | $946.36 | 17.0% |
| 85610 | Blood test, clotting time | Office | 2023 | 22 | 219 | $3,723 | $903.00 | 24.3% |
| 93279 | Programming of single lead pacemaker system | Office | 2023 | 11 | 17 | $2,635 | $847.87 | 32.2% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 12 | 12 | $4,776 | $650.76 | 13.6% |
About Dr. Scott Hacking, M.D
Dr. Scott Hacking, M.D is a Internal Medicine healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992712285.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Hacking, M.D has received a total of $25,013 in payments from pharmaceutical and medical device companies, with $2,280 received in 2024. These payments were reported across 905 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($16,160).
As a Medicare-enrolled provider, Hacking has provided services to 9,834 Medicare beneficiaries, totaling 17,109 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 116 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Interventional Cardiology
- Location Salt Lake City, UT
- Active Since 08/01/2006
- Last Updated 01/13/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1992712285
Products in Payments
- WATCHMAN (Device) $6,787
- Impella (Device) $1,439
- ELIQUIS (Drug) $1,300
- XARELTO (Drug) $1,262
- WATCHMAN Access System (Device) $1,227
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $1,150
- GENERAL - VASCULAR ACCESS (Device) $981.26
- ENTRESTO (Drug) $903.24
- Repatha (Biological) $643.74
- ELCAELCA X-80 (Device) $566.57
- CAMZYOS (Drug) $513.32
- WATCHMAN FLX (Device) $512.99
- JARDIANCE (Drug) $471.55
- BRILINTA (Drug) $346.32
- KENGREAL (Drug) $325.57
- LEQVIO (Drug) $316.21
- CVX-300CVX-300P (Device) $301.51
- VYNDAQEL (Drug) $280.98
- (5044) MCOT (Device) $269.45
- VERQUVO (Drug) $247.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Salt Lake City
Dr. Willard Dere, M.d, M.D
Internal Medicine — Payments: $5.4M
Internal Medicine $5.4M
Dr. Catherine Bakewell, M.d, M.D
Internal Medicine — Payments: $1.0M
Internal Medicine $1.0M
Dr. April Erwin, Md, MD
Internal Medicine — Payments: $381,757
Internal Medicine $381,757
Dr. Neeraj Agarwal, Md, MD
Internal Medicine — Payments: $344,790
Internal Medicine $344,790
George Rodgers, M.d, M.D
Internal Medicine — Payments: $229,629
Internal Medicine $229,629
James Chamberlain, Md, MD
Internal Medicine — Payments: $200,257
Internal Medicine $200,257